デフォルト表紙
市場調査レポート
商品コード
1575044

ヒト肝臓モデル市場:製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測

Human Liver Model Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 303 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヒト肝臓モデル市場:製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ヒト肝臓モデルの市場規模は、2023年に12億132万米ドルとなり、2024年から2032年にかけて10.99%のCAGRで拡大

ヒト肝臓モデル市場 - 市場力学

創薬・薬剤開発の市場開拓、3D細胞培養技術、肝疾患の蔓延が市場需要を促進する見込み

肝臓は薬物代謝の主要部位であるため、肝臓モデルは薬物代謝、毒性、有効性を試験するための創薬に不可欠です。精密医療や生物製剤を含む医薬品研究開発への製薬業界の投資拡大が、ヒト肝臓モデルの需要を増大させ、それが市場成長を後押ししています。3D細胞培養、マイクロ流体システム、臓器オンチッププラットフォームの技術的進歩により、より生理学的に適切な肝臓モデルの作製が可能になりました。これらの技術革新は、肝機能や肝反応のより優れたシミュレーションを提供し、研究者の採用を後押ししています。

肝炎、非アルコール性脂肪性肝疾患(NAFLD)、肝硬変、肝がんなどの肝疾患の罹患率が上昇していることから、高度な研究ツールや治療ソリューションに対するニーズが高まっています。その結果、病気のメカニズムを研究し、新しい治療を開発するための正確な肝臓モデルの需要が高まっています。規制機関や科学界は、動物実験を減らすための代替試験法を求めています。肝臓オルガノイドやLiver-on-a-chipシステムなどのヒト肝臓モデルは、実行可能なin vitro代替法を提供し、市場の成長を促進しています。世界中の政府や研究機関は、肝モデルを含む臓器モデリング技術の向上を目的としたプロジェクトへの資金提供を増やしています。こうした資金援助により、革新的な肝臓モデルの開発と商業化が加速しています。

ヒト肝臓モデル市場 - 主要な洞察

リサーチアナリストの分析によると、世界市場は予測期間(2024年~2032年)に約10.99%のCAGRで毎年成長すると予測されています。

製品タイプ別では、製薬研究および医薬品開発への応用が高いことから、2Dモデルセグメントが2023年に最大市場シェアを示すと予測されています。

用途別では、先進肝臓モデルの需要加速により、ADME研究分野が2023年の主要用途分野となりました。

エンドユーザーセグメントに基づくと、薬物間相互作用や薬物代謝などの評価における肝臓モデルのニーズの高まりにより、バイオ製薬企業セグメントが2023年の主要エンドユーザーセグメントでした。

地域別では、北米が2023年の収益をリードしましたが、これは支持的な規制環境のためです。

ヒト肝臓モデル市場 - セグメンテーション分析:

世界のヒト肝臓モデル市場は、製品タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプによって2つに分類されます:2Dモデルと3Dモデルです。2Dモデルは市場を独占しています。疾患モデリングやin vivo条件下での用途の増加が、主にこのセグメントの成長を後押ししています。

市場は用途によって4つに分類されます:ADME試験、毒性試験、疾患モデリング、その他です。ADME試験分野が市場を独占しています。毒性試験分野は、in-vitro試験からの需要の高まりにより、予測期間中に最も速いCAGRで拡大すると推定されます。

市場はエンドユーザーによって3つのカテゴリーに分けられます。CRO、学術研究です。バイオ製薬企業セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。肝臓モデルは、バイオ医薬品企業が医薬品開発プロセスの精度を迅速に評価するのに役立ちます。

ヒト肝臓モデル市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。北米は、大手製薬会社やバイオテクノロジー企業が存在し、研究機関の数が多く、ヘルスケアのインフラが発達しているため、世界のヒト肝臓モデル市場で大きなシェアを占めています。アジア太平洋地域は、バイオテクノロジーへの投資の増加、製薬産業の拡大、肝臓疾患の有病率の上昇を背景に、ヒト肝臓モデル市場で急速な成長を遂げています。中国やインドのような国々への製薬および臨床研究のアウトソーシングの増加、生物医学研究に対する政府資金の増加しています。

ヒト肝臓モデル市場 - 競合情勢:

ヒト肝臓モデル市場の競合情勢は、既存企業、革新的新興企業、研究機関など、さまざまな企業によって形成されています。これらの企業は、薬剤試験や疾患モデリングなどの需要の高まりに対応するため、高度な肝臓モデルの開発に注力しています。企業は、3Dバイオプリント肝臓組織やマイクロ流体liver-on-chipデバイスなど、より生理学的に適切な肝臓モデルの開発に注力しています。主要企業は製薬会社や学術機関と協力し、肝臓モデルの検証や商品化を進めています。

2024年4月、CN Bio Innovationsは、Organ-on-a-chip(OOC)技術を開発するため、シリーズBで2,100万米ドルの資金を獲得しました。

2022年、InSphero AGはNASHと肝線維症研究のための先進モデルを発表し、複雑な肝疾患のより良いin vitroモデリングを可能にしました。

目次

第1章 ヒト肝臓モデル市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ヒト肝臓モデルの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ヒト肝臓モデル産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ヒト肝臓モデル市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 ヒト肝臓モデルの市場情勢

  • ヒト肝臓モデルの市場シェア分析、2023年
  • 内訳データ:主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 ヒト肝臓モデル市場 - 製品タイプ別

  • 概要
    • セグメントシェア分析:製品タイプ別
    • 2Dモデル
    • 3Dモデル

第8章 ヒト肝臓モデル市場 - 用途別

  • 概要
    • セグメントシェア分析:用途別
    • ADME研究
    • 毒性試験
    • 疾患モデル化
    • その他

第9章 ヒト肝臓モデル市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析:エンドユーザー別
    • バイオ医薬品企業
    • CRO
    • 学術研究

第10章 ヒト肝臓モデル市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - ヒト肝臓モデル業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Emulate, Inc.
    • Organovo Holdings, Inc.
    • InSphero AG
    • Cyfuse Biomedical K.K.
    • CN Bio Innovations
    • BioIVT
    • Hurel Corporation
    • HepaRG
    • Kirkstall Ltd.
    • TissUse GmbH
    • MIMETAS B.V.
    • CellSystems Biotechnologie Vertrieb GmbH
    • Promega Corporation
    • Merck KGaA
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV4046

REPORT HIGHLIGHT

Human Liver Model Market size was valued at USD 1,201.32 Million in 2023, expanding at a CAGR of 10.99% from 2024 to 2032.

The human liver model is an experimental or computational representation of the human liver used for research and medical purposes. These models are designed to study liver function, disease, and drug interactions in a controlled environment. There are several types of human liver models, each serving distinct purposes.

Human Liver Model Market- Market Dynamics

Growth in drug discovery & development, 3D cell culture technology and prevalence of liver disorders is expected to propel market demand

Liver models are essential in drug discovery for testing drug metabolism, toxicity, and efficacy, as the liver is a primary site of drug metabolism. The pharmaceutical industry's growing investment in drug research and development, including precision medicine and biologics, has increased the demand for human liver models, which in turn is boosting market growth. Technological advancements in 3D cell culture, microfluidic systems, and organ-on-a-chip platforms have enabled the creation of more physiologically relevant liver models. These innovations offer better simulation of liver function and response, encouraging adoption by researchers.

The rising incidence of liver diseases such as hepatitis, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and liver cancer has led to an increased need for advanced research tools and therapeutic solutions. This, in turn, drives the demand for accurate liver models for studying disease mechanisms and developing new treatments. Regulatory bodies and the scientific community are pushing for alternative testing methods to reduce animal testing. Human liver models, including liver organoids and liver-on-a-chip systems, provide a viable in vitro alternative, driving market growth. Governments and research institutions worldwide are increasingly funding projects aimed at improving organ modeling technologies, including liver models. This funding accelerates the development and commercialization of innovative liver models.

Human Liver Model Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.99% over the forecast period (2024-2032)

Based on Product Type segmentation, the 2D models segment was predicted to show maximum market share in the year 2023, owing to its high applications in pharmaceutical research & drug development.

Based on Application segmentation, ADME studies segment was the leading Application segment in 2023, due to the accelerating demand for advanced liver models.

Based on End User segmentation, biopharmaceutical companies' segment was the leading End User segment in 2023, due to the growing need for liver models in assessing drug-drug interactions, drug metabolism, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the supportive regulatory environment.

Human Liver Model Market- Segmentation Analysis:

Global Human Liver Model Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: 2D models and 3D models. The 2D models segment dominates the market. Increasing application in disease modelling and in vivo conditions is mainly fueling segment growth.

The market is divided into four categories based on Application: ADME studies, toxicology testing, disease modelling and others. The ADME studies segment dominates the market. The toxicology testing segment is estimated to expand at the fastest CAGR over the forecast period with rising demand from in-vitro testing.

The market is divided into three categories based on End User: biopharmaceutical companies. CROs, and academic research. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Liver models help biopharma companies to assess accuracy of their drug development processes in rapid time.

Human Liver Model Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global human liver model market due to the presence of major pharmaceutical and biotechnology companies, a high number of research institutions, and advanced healthcare infrastructure. The Asia-Pacific region is experiencing rapid growth in the human liver model market, driven by increasing investment in biotechnology, expanding pharmaceutical industries, and rising prevalence of liver diseases. Growing pharmaceutical and clinical research outsourcing to countries like China and India, increasing government funding for biomedical research.

Human Liver Model Market- Competitive Landscape:

The competitive landscape of the human liver model market is shaped by a variety of companies, including established players, innovative startups, and research organizations. These companies are focusing on developing advanced liver models to cater to the growing demand for drug testing, disease modeling, etc. Companies are focusing on developing more physiologically relevant liver models, such as 3D bio printed liver tissues and microfluidic liver-on-chip devices. Key players are collaborating with pharmaceutical companies and academic institutions to validate and commercialize their liver models.

In April 2024, CN Bio Innovations received USD 21 million in Series-B funding to develop its organ-on-a-chip (OOC) technologies.

In 2022, InSphero AG introduced advanced models for NASH and liver fibrosis research, enabling better in vitro modeling of complex liver diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN LIVER MODEL MARKET KEY PLAYERS

  • Emulate, Inc.
  • Organovo Holdings, Inc.
  • InSphero AG
  • Cyfuse Biomedical K.K.
  • CN Bio Innovations
  • BioIVT
  • Hµrel Corporation
  • HepaRG
  • Kirkstall Ltd.
  • TissUse GmbH
  • MIMETAS B.V.
  • Insphero AG
  • CellSystems Biotechnologie Vertrieb GmbH
  • Promega Corporation
  • Merck KGaA
  • Others

GLOBAL HUMAN LIVER MODEL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • 2D Models
  • 3D Models

GLOBAL HUMAN LIVER MODEL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • ADME studies
  • Toxicology testing
  • Disease modelling
  • Others

GLOBAL HUMAN LIVER MODEL MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • CROs
  • Academic Research

GLOBAL HUMAN LIVER MODEL MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Liver Model Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Liver Model Market Snippet by Product Type
    • 2.1.2. Human Liver Model Market Snippet by Application
    • 2.1.3. Human Liver Model Market Snippet by End User
    • 2.1.4. Human Liver Model Market Snippet by Country
    • 2.1.5. Human Liver Model Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Liver Model Key Market Trends

  • 3.1. Human Liver Model Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Liver Model Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Liver Model Market Opportunities
  • 3.4. Human Liver Model Market Future Trends

4. Human Liver Model Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Liver Model Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Liver Model Market Landscape

  • 6.1. Human Liver Model Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Liver Model Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. 2D Models
    • 7.1.3. 3D Models

8. Human Liver Model Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. ADME studies
    • 8.1.3. Toxicology testing
    • 8.1.4. Disease modelling
    • 8.1.5. Others

9. Human Liver Model Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Companies
    • 9.1.3. CROs
    • 9.1.4. Academic Research

10. Human Liver Model Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Human Liver Model Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Human Liver Model Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Human Liver Model Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Human Liver Model Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Human Liver Model Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Human Liver Model Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Emulate, Inc.
    • 11.2.2. Organovo Holdings, Inc.
    • 11.2.3. InSphero AG
    • 11.2.4. Cyfuse Biomedical K.K.
    • 11.2.5. CN Bio Innovations
    • 11.2.6. BioIVT
    • 11.2.7. Hurel Corporation
    • 11.2.8. HepaRG
    • 11.2.9. Kirkstall Ltd.
    • 11.2.10. TissUse GmbH
    • 11.2.11. MIMETAS B.V.
    • 11.2.12. Insphero AG
    • 11.2.13. CellSystems Biotechnologie Vertrieb GmbH
    • 11.2.14. Promega Corporation
    • 11.2.15. Merck KGaA
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us